Found: 178
Select item for more details and to access through your institution.
Alemtuzumab clearance, lymphocyte count, and T‐cell chimerism after hematopoietic stem cell transplant in sickle cell disease.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 1, p. 14, doi. 10.1002/phar.2641
- By:
- Publication type:
- Article
COVID‐19 Clinical Diagnostics and Testing Technology.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 8, p. 857, doi. 10.1002/phar.2439
- By:
- Publication type:
- Article
Pharmacokinetics of Intravenous Voriconazole in Obese Patients: Implications of CYP2C19 Homozygous Poor Metabolizer Genotype.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 3, p. e19, doi. 10.1002/phar.1192
- By:
- Publication type:
- Article
Lack of Association Between Excretion of Sorafenib in Sweat and Hand-Foot Skin Reaction.
- Published in:
- Pharmacotherapy, 2010, v. 30, n. 1, p. 52, doi. 10.1592/phco.30.1.52
- By:
- Publication type:
- Article
Pharm.D. Pathways to Biomedical Research: The National Institutes of Health Special Conference on Pharmacy Research.
- Published in:
- 2008
- By:
- Publication type:
- Proceeding
Chemoprevention in Prostate Cancer.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Scientific Collaboration Results in Higher Citation Rates of Published Articles.
- Published in:
- Pharmacotherapy, 2006, v. 26, n. 6, p. 759, doi. 10.1592/phco.26.6.759
- By:
- Publication type:
- Article
The differentiating agent phenylacetate increases prostate-specific antigen production by prostate cancer cells.
- Published in:
- Prostate, 1996, v. 29, n. 3, p. 177, doi. 10.1002/(SICI)1097-0045(199609)29:3<177::AID-PROS3>3.0.CO;2-B
- By:
- Publication type:
- Article
Checkpoint inhibitor immunotherapy during pregnancy for relapsed–refractory Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 833, doi. 10.1002/ajh.26527
- By:
- Publication type:
- Article
Racial Disparities in the Association Between Variants on 8q24 and Prostate Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Oncologist, 2012, v. 17, n. 3, p. 312, doi. 10.1634/theoncologist.2011-0315
- By:
- Publication type:
- Article
Angiogenesis Inhibitors: Current Strategies and Future Prospects.
- Published in:
- CA: A Cancer Journal for Clinicians, 2010, v. 60, n. 4, p. 222, doi. 10.3322/caac.20075
- By:
- Publication type:
- Article
Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 695, p. 1, doi. 10.1126/scitranslmed.abq6089
- By:
- Publication type:
- Article
Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 625, p. 1, doi. 10.1126/scitranslmed.abd8077
- By:
- Publication type:
- Article
Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1131, doi. 10.3390/cancers14051131
- By:
- Publication type:
- Article
Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease Management.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2154, doi. 10.3390/cancers13092154
- By:
- Publication type:
- Article
Pharmacokinetic Simulation Analysis of Less Frequent Nivolumab and Pembrolizumab Dosing: Pharmacoeconomic Rationale for Dose Deescalation.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 532, doi. 10.1002/jcph.1984
- By:
- Publication type:
- Article
TMPRSS2: Potential Biomarker for COVID‐19 Outcomes.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 801, doi. 10.1002/jcph.1641
- By:
- Publication type:
- Article
Pharmacogenomics Implementation at the National Institutes of Health Clinical Center.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, p. S67, doi. 10.1002/jcph.993
- By:
- Publication type:
- Article
Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 12, p. 1484, doi. 10.1002/jcph.765
- By:
- Publication type:
- Article
Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 4, p. 461, doi. 10.1002/jcph.625
- By:
- Publication type:
- Article
UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 4, p. 450, doi. 10.1002/jcph.627
- By:
- Publication type:
- Article
Phase I Study of Oral Lenalidomide in Patients With Refractory Metastatic Cancer.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 6, p. 650, doi. 10.1177/0091270009335001
- By:
- Publication type:
- Article
Phase I Study of Oral Lenalidomide in Patients With Refractory Metastatic Cancer.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 6, p. 650, doi. 10.1177/0091270009335001
- By:
- Publication type:
- Article
Review of UCN-01 Development: A Lesson in the Importance of Clinical Pharmacology.
- Published in:
- Journal of Clinical Pharmacology, 2005, v. 45, n. 4, p. 394, doi. 10.1177/0091270005274549
- By:
- Publication type:
- Article
Influence of Genetic Variants in UGT1A1 and UGT1A9 on the in Vivo Glucuronidation of SN-38.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 8, p. 854
- By:
- Publication type:
- Article
Factors Involved in the Pharmacokinetics of COL-3, a Matrix Metalloproteinase Inhibitor, in Patients with Refractory Metastatic Cancer: Clinical and Experimental Studies.
- Published in:
- Journal of Clinical Pharmacology, 2003, v. 43, n. 10, p. 1124, doi. 10.1177/0091270003256675
- By:
- Publication type:
- Article
Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models.
- Published in:
- Marine Drugs, 2018, v. 16, n. 7, p. 241, doi. 10.3390/md16070241
- By:
- Publication type:
- Article
Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC)patients.
- Published in:
- BMC Cancer, 2010, v. 10, p. 511, doi. 10.1186/1471-2407-10-511
- By:
- Publication type:
- Article
Pharmacy Education: Back to the Basics?
- Published in:
- 2003
- By:
- Publication type:
- Editorial
Increased Frequency of Venous Thromboembolism with the Combination of Docetaxel and Thalidomide in Patients with Metastatic Androgen-Independent Prostate Cancer.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 3, p. 315
- By:
- Publication type:
- Article
2-Methoxyestradiol, a Promising Anticancer Agent.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 2, p. 165, doi. 10.1592/phco.23.2.165.32088
- By:
- Publication type:
- Article
Relugolix in Clinical Practice: The Best Route for All?
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 647, doi. 10.1093/oncolo/oyad099
- By:
- Publication type:
- Article
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 642, doi. 10.1093/oncolo/oyad058
- By:
- Publication type:
- Article
Evidence Regarding Pharmacogenetics in Pain Management and Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 189, doi. 10.1093/oncolo/oyac277
- By:
- Publication type:
- Article
Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. e273, doi. 10.1093/oncolo/oyab073
- By:
- Publication type:
- Article
Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single‐Dose Administration Under Fasting Conditions in Prostate Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 729, doi. 10.1002/onco.13919
- By:
- Publication type:
- Article
PARP Inhibitors and Prostate Cancer: To Infinity and Beyond BRCA.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. e115, doi. 10.1634/theoncologist.2020-0697
- By:
- Publication type:
- Article
A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma.
- Published in:
- Oncologist, 2017, v. 22, n. 5, p. 505, doi. 10.1634/theoncologist.2016-0486
- By:
- Publication type:
- Article
Preclinical Evaluation of a Novel Series of Polyfluorinated Thalidomide Analogs in Drug-Resistant Multiple Myeloma.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 6, p. 725, doi. 10.3390/biom14060725
- By:
- Publication type:
- Article
Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2010, v. 29, p. 95, doi. 10.1186/1756-9966-29-95
- By:
- Publication type:
- Article
Clinical protocol: Feasibility of evaluating abemaciclib neuropharmacokinetics of diffuse midline glioma using intratumoral microdialysis.
- Published in:
- PLoS ONE, 2023, v. 18, n. 9, p. 1, doi. 10.1371/journal.pone.0291068
- By:
- Publication type:
- Article
In Silico Re‐Optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure–Response Simulation.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 672, doi. 10.1002/jcph.2203
- By:
- Publication type:
- Article
In memoriam Michelle A. Rudek (1972–2023).
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 1, p. 1, doi. 10.1111/cts.13705
- By:
- Publication type:
- Article
Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs.
- Published in:
- Molecules, 2020, v. 25, n. 23, p. 5683, doi. 10.3390/molecules25235683
- By:
- Publication type:
- Article
The Role of an Androgen Receptor Polymorphism in the Clinical Outcome of Patients with Metastatic Prostate Cancer.
- Published in:
- Urologia Internationalis, 2002, v. 68, n. 1, p. 16, doi. 10.1159/000048412
- By:
- Publication type:
- Article
A Phase II Trial of Gallium Nitrate in Patients with Androgen-Metastatic Prostate Cancer.
- Published in:
- Urologia Internationalis, 1999, v. 63, n. 2, p. 120, doi. 10.1159/000030430
- By:
- Publication type:
- Article
Reversible sideroblastic anemia associated with the tetracycline analogue COL-3.
- Published in:
- American Journal of Hematology, 2001, v. 67, n. 1, p. 51, doi. 10.1002/ajh.1076
- By:
- Publication type:
- Article
Severe thrombocytopenia in patients treated with suramin: Evidence for an immune mechanism in one.
- Published in:
- American Journal of Hematology, 1996, v. 51, n. 2, p. 152, doi. 10.1002/(SICI)1096-8652(199602)51:2<152::AID-AJH10>3.0.CO;2-K
- By:
- Publication type:
- Article
Integrating pharmacogenetic information and clinical decision support into the electronic health record.
- Published in:
- Journal of the American Medical Informatics Association, 2014, v. 21, n. 3, p. 522, doi. 10.1136/amiajnl-2013-001873
- By:
- Publication type:
- Article